Effect of Mopidamol on Survival in Carcinoma of the Lung and Colon: Final Report of Veterans Administration Cooperative Study No. 188
Authors:
- 16 March 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 80 (2) , 90-97
Abstract
Mopidamol (RA-233), a derivative of dipyridamole, is a phosphodiesterase inhibitor that has been shown previously to limit progression of malignancy in certain experimental animal models and in a pilot study in humans. RA-233 plus chemotherapy was compared with chemotherapy alone in a 5-year double-blind trial involving 719 patients with advanced carcinomas of the lung and of the colon. RA-233 treatment was associated with a statistically significant prolongation of survival in patients with non-small cell lung cancer (N-SCLC) limited to one hemithorax and with reduction in mean plasma fibrogen concentration. RA-233 was not toxic. The favorable effects on survival could not be explained by any factor other than the RA-233 treatment. In other tumor categories tested, no differences in survival were observed. These results suggest that RA-233 is useful in the treatment of N-SCLC of limited extent. They also suggest that therapeutic intervention aimed at modified intracellular pathways might constitute a novel investigative approach to the treatment of cancer.Keywords
This publication has 27 references indexed in Scilit:
- EFFECTS OF DIBUTYRYL CYCLIC ADENOSINE 3'-5'-MONOPHOSPHATE ON THE GROWTH OF CULTURED HUMAN SMALL-CELL LUNG-CARCINOMA AND THE SPECIFIC CELLULAR-ACTIVITY OF L-DOPA DECARBOXYLASE1983
- Modulation of Tumor Cell Adherence by ProstaglandinsOncology, 1983
- Platelets and malignancy Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancerAmerican Journal of Clinical Oncology, 1982
- Cyclic Nucleotide-induced Maturation of Human Promyelocytic Leukemia CellsJournal of Clinical Investigation, 1982
- The effect of 2,6-bis(diethanolamino)-4-piperidinopyrimido [5,4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanomaCancer Letters, 1982
- Effects of cyclic nucleotides on the shedding of tumor cell surface membranesExperimental Cell Research, 1982
- INTERRUPTION OF TUMOR-ASSOCIATED PLATELET CONSUMPTION WITH PLATELET ENZYME-INHIBITORS1982
- Rationale and experimental design for the va cooperative study of anticoagulation (warfarin) in the treatment of cancerCancer, 1979
- Comparison of the Reaction-rate and Clot-density Methods for Determination of Plasma FibrinogenAmerican Journal of Clinical Pathology, 1977
- The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL)Journal of Cancer Research and Clinical Oncology, 1976